• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 114-128 of 514 results

TYVASO

Docket 022387, Orange Book (July 30, 2009)

cite Cite Docket
Analyze

TREPROSTINIL ADMINISTRATION BY INHALATION

Docket 12/591,200, U.S. Patent Application (Nov. 12, 2009)

cite Cite Docket
Analyze

Letter

Document TYVASO, 022387, Letter (Orange Book Oct. 19, 2017)

cite Cite Document
Analyze

Label

Document TYVASO, 022387, Label (Orange Book Oct. 19, 2017)

cite Cite Document
Analyze

2210 Exhibit: Transcript of teleconference between the parties and the Board, June...

Document IPR2017-01621, No. 2210-325 Exhibit - Transcript of teleconference between the parties and the Board, June 20, 2018 (P.T.A.B. Jun. 26, 2018)

cite Cite Document
Analyze

2095 Exhibit: McLaughlin VV et al, Addition of Inhaled Treprostinil to Oral Therapy f...

Document IPR2017-01621, No. 2095-308 Exhibit - McLaughlin VV et al, Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension A Randomized Controlled Clinical Trial, JACC, 18...

cite Cite Document
Analyze

2038 Exhibit: Second Declaration of Dr Richard Dalby

Document IPR2017-01621, No. 2038-246 Exhibit - Second Declaration of Dr Richard Dalby (P.T.A.B. Apr. 27, 2018)

cite Cite Document
Analyze

2037 Exhibit: Listing of Issues and Supplements of Circulation Accessible on Circul...

Document IPR2017-01621, No. 2037-245 Exhibit - Listing of Issues and Supplements of Circulation Accessible on Circulation Website accessed April 17, 2018 (P.T.A.B. Apr. 27, 2018)

cite Cite Document
Analyze

1110 Exhibit: Gilead, Form 10 K, 2015

Document IPR2017-01621, No. 1110-103 Exhibit - Gilead, Form 10 K, 2015 (P.T.A.B. Jun. 21, 2017)

cite Cite Document
Analyze

1047 Exhibit: Sulica, R and Poon, M Medical Therapeutics for Pulmonary Arterial H...

Document IPR2017-01621, No. 1047-43 Exhibit - Sulica, R and Poon, M Medical Therapeutics for Pulmonary Arterial Hypertension From Basic Science and Clinical Trial Design to Evidence Based Medicine...

cite Cite Document
Analyze

2102 Exhibit: LungRx TRIUMPH Executive Committee Meeting Agenda dated Octo...

Document IPR2017-01621, No. 2102-319 Exhibit - LungRx TRIUMPH Executive Committee Meeting Agenda dated October 22, 2003 (P.T.A.B. Apr. 27, 2018)

cite Cite Document
Analyze

2035 Exhibit: Transcript from April 6, 2018 Deposition of Dr DeForest McDuff, Part 1...

Document IPR2017-01621, No. 2035-242 Exhibit - Transcript from April 6, 2018 Deposition of Dr DeForest McDuff, Part 1 of 2 (P.T.A.B. Apr. 27, 2018)

cite Cite Document
Analyze

1155 Exhibit: UTC, Form 10 K, 2013

Document IPR2017-01621, No. 1155-151 Exhibit - UTC, Form 10 K, 2013 (P.T.A.B. Jun. 21, 2017)

cite Cite Document
Analyze

1073 Exhibit: Actelion Pharmaceuticals, Annual Report, 2016

Document IPR2017-01621, No. 1073-66 Exhibit - Actelion Pharmaceuticals, Annual Report, 2016 (P.T.A.B. Jun. 21, 2017)

cite Cite Document
Analyze

1093 Exhibit: FDA Drug Details Website, Remodulin, httpswwwaccessdatafdagovsc...

Document IPR2017-01621, No. 1093-86 Exhibit - FDA Drug Details Website, Remodulin, httpswwwaccessdatafdagovscriptscderdafindexcfmeventBasicSearchprocess accessed 5172017 (P.T.A.B. Jun. 21...

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 8 9 10 11 12 ... >>